Exposure to Mitomycin C (MMC) has been shown to increase ROS production in RA-FLS and disrupt ΔΨ m, increasing the release of mitochondrial cytochrome c and the ratio of Bax/Bcl-2 and inducing apoptosis in RA-FLS (130). This evidence concerns the gene BCL2 and rheumatoid arthritis.